Related Experiment Video
Updated: Aug 15, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding
Helmut R Salih1, Hans-Georg Rammensee, Alexander Steinle
1Department of Internal Medicine II, University Hospital, Eberhard-Karls-University, Auf der Morgenstelle 15, 72076 Tubingen, Germany.
Abstract:
The immunoreceptor NKG2D stimulates tumor immunity through activation of CD8 T cells and NK cells. Its ligand MICA has been shown to be broadly expressed on human tumors of epithelial origin. MICA expression correlates with an enrichment of Vdelta1 T cells in tumor tissue. We report that human tumor cells spontaneously release a soluble form of MICA encompassing the three extracellular domains, which is present at high levels in sera of patients with gastrointestinal malignancies, but not in healthy donors. Release of MICA from tumor cells is blocked by inhibition of metalloproteinases, concomitantly causing accumulation of MICA on the cell surface. Shedding of MICA by tumor cells may modulate NKG2D-mediated tumor immune surveillance. In addition, determination of soluble MICA levels may be implemented as an immunological diagnostic marker in patients with epithelial malignancies.
Insights
Tumor cells release soluble MICA, a protein that may impact immune surveillance. Soluble MICA levels are elevated in cancer patients, suggesting its potential as a diagnostic marker for epithelial malignancies.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- The NKG2D receptor plays a crucial role in tumor immunity by activating CD8 T cells and NK cells.
- Its ligand, MICA, is widely expressed on human epithelial tumors and its presence correlates with Vdelta1 T cell enrichment in tumor tissues.
Purpose of the Study:
- To investigate the release of soluble MICA from tumor cells.
- To explore the potential of soluble MICA as a diagnostic marker for epithelial malignancies.
Main Methods:
- Analysis of MICA shedding from human tumor cells.
- Measurement of soluble MICA levels in patient sera using immunological assays.
- Inhibition of metalloproteinases to study MICA release.
Main Results:
- Human tumor cells spontaneously release a soluble form of MICA.
- Soluble MICA is found at high levels in the sera of patients with gastrointestinal malignancies but not in healthy donors.
- Inhibiting metalloproteinases blocks MICA release and increases cell surface MICA accumulation.
Conclusions:
- Tumor cell-derived soluble MICA may modulate NKG2D-mediated tumor immune surveillance.
- Soluble MICA levels could serve as an immunological diagnostic marker for epithelial malignancies.
Related Concept Videos
MicroRNAs
Experimental RNAi
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
MicroRNAs

